jimki

The Role of Maternal Hematological Conditions in the Incidence of Neonatal Jaundice

Authors

  • Heriqza Arza Dinnur Maulana

    Program Studi Pendidikan Dokter, Fakultas Kedokteran, Universitas Lampung, Bandar Lampung
  • Efriyan Imantika

    Bagian Obsetri dan Ginekologi, RSUD Dr. H. Abdul Moeloek, Bandar Lampung
  • Muhammad Maulana

    Program Studi Pendidikan Dokter, Fakultas Kedokteran, Universitas Lampung, Bandar Lampung
  • Rodiani

    Bagian Obsetri dan Ginekologi, RSUD Dr. H. Abdul Moeloek, Bandar Lampung

DOI:

https://doi.org/10.53366/jimki.v12i3.1069

Keywords:

Keywords: Neonatal jaundice; maternal hematologic conditions; maternal risk factors.

Abstract

Introduction: Neonatal jaundice is a common clinical condition that can progress to serious complications if left untreated. Several studies have shown that maternal hematological conditions play a significant role in influencing the risk of hyperbilirubinemia in neonates.

Methods: This literature review utilized six nationally and internationally indexed articles (2020–2025), selected through the PRISMA pathway, focusing on the association of maternal hematological factors with the incidence of neonatal jaundice.

Results: The reviewed studies identified several maternal hematological determinants, including elevated WBC and MCV, anemia, PROM, GDM, and ABO and Rh incompatibility, as contributing factors to an increased risk of hyperbilirubinemia. Obstetric factors such as maternal age, duration of labor, and maternal disease also strengthen this association.

Discussion: Maternal hematological conditions influence neonatal jaundice through mechanisms of hemolysis, inflammation, immunological disorders, and the fetus's metabolic inability to manage bilirubin. The interaction between maternal hematological status and obstetrical events exacerbates neonatal erythrocyte instability and increases bilirubin accumulation.

Conclusion: Maternal hematological status is an important determinant of neonatal jaundice, therefore, increased hematological monitoring in pregnant women is necessary as a preventive measure to reduce the risk of hyperbilirubinemia in newborns.

References

1. Tessema M, Mekonnen H, Alemu T, Godie Y, Teklehaimanot WZ, Mengstie LA. Magnitude and its associated factors of neonatal jaundice among neonates admitted to the neonatal intensive care unit of Dessie Town public hospitals, Amhara region, Ethiopia, 2020: a multicenter cross-sectional study. Front Pediatr. 2024;12(January):1-8. doi:10.3389/fped.2024.1288604

2. Diala UM, Usman F, Appiah D, et al. Global Prevalence of Severe Neonatal Jaundice among Hospital Admissions: A Systematic Review and Meta-Analysis. J Clin Med. 2023;12(11):3738. doi:10.3390/jcm12113738

3. Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC. Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity. Front Pediatr. 2022;10. doi:10.3389/fped.2022.875877

4. Fatriani R. Faktor Risiko Yang Berhubungan Dengan Kejadian Ikterus Neonatorum Pada Bayi Baru Lahir. J Kesehat Panca Bhakti Lampung. 2020;8(1):47. doi:10.47218/jkpbl.v8i1.78

5. Parastatidou S, Tsantes AG, Emmanouil CC, Konstantinidi A, Kapetanaki A, Sokou R. Neonatal Hemolytic Jaundice: Causes, Diagnostic Approach, and Management. Children. 2025;12(6):666. doi:10.3390/children12060666

6. WHO. Anaemia in Women and Children.; 2025. https://www.who.int/data/gho/data/themes/topics/anaemia_in_women_and_children

7. Tibar SLA, Maternity D, Isnaini N. Factors Affecting The Incidence Of Anemia In Pregnant Women. JKM (Jurnal Kebidanan Malahayati). 2025;11(3):207-219. doi:10.33024/jkm.v11i3.7900

8. Jiang N, Qian L, Lin G, et al. Maternal blood parameters and risk of neonatal pathological jaundice: a retrospective study. Sci Rep. 2023;13(1):1-7. doi:10.1038/s41598-023-28254-3

9. Executive P. PRISMA 2020. 2025. https://www.prisma-statement.org/prisma-2020

10. Ayalew T, Molla A, Kefale B, et al. Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study. BMC Pregnancy Childbirth. 2024;24(1):1-10. doi:10.1186/s12884-024-06352-y

11. Yu Y, Choi J, Lee MH, Kim KH, Ryu HM, Han HW. Maternal disease factors associated with neonatal jaundice: a case–control study. BMC Pregnancy Childbirth. 2022;22(1). doi:10.1186/s12884-022-04566-6

12. Warsame HA, Theuri C, Abdullahi NM, Ahmed Keynan AM, Ahmed MAM. Prevalence and risk factors for neonatal jaundice: A multicentre analytical cross-sectional study at neonatal intensive care units, Mogadishu, Somalia. BMJ Open. 2025;15(3). doi:10.1136/bmjopen-2024-096692

13. Isa HM, Albuainain NY, Bunajem FY, Masood AS, Bucheery YA. Neonatal and Maternal Risk Factors for Indirect Hyperbilirubinemia: A Cross-Sectional Study from Bahrain. Int J Pediatr (United Kingdom). 2022;2022. doi:10.1155/2022/5199423

Published

2026-01-14

How to Cite

The Role of Maternal Hematological Conditions in the Incidence of Neonatal Jaundice. (2026). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 12(3), 865-878. https://doi.org/10.53366/jimki.v12i3.1069